Genexa is a clean medicine company that researches and develops medicine.
Genexa has raised $60.0M in total funding. The most recent round was Series A. The last funding was announced in July 2021.
Genexa's investors include Unilever Ventures, North Castle Partners, Verlinvest, Brandon Shainfeld, Bill Silva Ventures.
Genexa is headquartered in Atlanta, United States.
Genexa is a clean medicine company that researches and develops medicine.
Genexa is at the Series A stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Genexa — Funding & Investors." VCBacked, July 14, 2021, https://www.vcbacked.co/company/genexa. Accessed August 14, 2026.
VCBacked. (2021). Genexa — Funding & Investors. Retrieved August 14, 2026, from https://www.vcbacked.co/company/genexa
{{cite web |title=Genexa — Funding & Investors |url=https://www.vcbacked.co/company/genexa |website=VCBacked |access-date=August 14, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated